Acute-onset psychosis induced by a therapeutic dose of parenteral hyoscine butylbromide: A case report

Authors

DOI:

https://doi.org/10.32677/ijcr.v9i3.3881

Keywords:

Psychosis, hallucination, Hyoscine butylbromide, anticholinergics, physostigmine

Abstract

Anticholinergic medications are frequently prescribed for gastrointestinal and genitourinary spasms. Psychosis, when present, results from anticholinergic overdose or toxicity. In the literature, anticholinergic-induced psychosis at therapeutic doses in patients with normal cognition is extremely uncommon. Here, we describe the case of a 28-year-old female who presented with auditory and visual hallucinations, stereotypy, and agitation after receiving a single intramuscular injection of 20 mg hyoscine butylbromide for dysmenorrhea. Even though it is rare for a therapeutic dose of hyoscine butylbromide to cause psychosis, clinicians should maintain a high index of suspicion and be cautious when administering or prescribing anticholinergics.

Downloads

Download data is not yet available.

Downloads

Published

2024-01-31

Issue

Section

Case Report

How to Cite

Acute-onset psychosis induced by a therapeutic dose of parenteral hyoscine butylbromide: A case report. (2024). Indian Journal of Case Reports, 9(3), 65-67. https://doi.org/10.32677/ijcr.v9i3.3881

Most read articles by the same author(s)

<< < 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 > >>